Latest News
US close: Dow picks up more than 320 points on vaccine rally
Wall Street stocks closed higher on Monday as another round of positive Covid-19 vaccine headlines boosted optimism among traders.
Tuesday preview: IFO index, ECB's Lagarde
Financial markets will be focused on Tuesday on the IFO institute's closely-followed business confidence gauge for November.
Europe close: Stocks give back early gains
European shares pared early gains on Monday even after positive news around AstraZeneca's Covid-19 vaccine.
London close: Stocks mixed on stronger pound, vaccine news
London stocks closed mixed on Monday, as investors weighed a positive update on AstraZeneca’s Covid-19 vaccine, with news that UK business activity shrank in November as the second lockdown took its toll.
Director dealings: CMC Markets deputy CEO lowers stake
CMC Markets revealed on Monday that deputy chief executive David Fineburg and his spouse Victoria had disposed of 253,857 ordinary shares in the FTSE 250-listed trading platform operator.
Broker tips: Sage, SSE, Barclays, NatWest
Analysts at Canaccord Genuity lowered their target price on software group Sage from 790. 0p to 700. 0p on Monday despite the group's full-year results coming in ahead of expectations.
Advanced Medical Solutions buys coatings firm Raleigh
Surgical and wound care specialist Advanced Medical Solutions Group (AMS) has acquired independent wound care and bio-diagnostics coatings company Raleigh Adhesive Coatings for £22m in cash, it announced on Monday.
FTSE 250 movers: Travel and leisure-related stocks jump, gold miners retreat
Leisure and Travel-related stocks paced gains on the second-tier index at the start of the week, after AstraZeneca and Oxford University presented interim clinical trial data showing 70% efficacy for the Covid-19 vaccine candidate.
Ariana posts decent quarter at Kiziltepe
Europe-focusses exploration and development company Ariana Resources announced operating results for the quarter ended 30 September for the Kiziltepe Mine in Turkey on Monday.
US open: Traders optimistic following another round of positive vaccine headlines
Wall Street stocks opened higher on Monday as another round of positive Covid-19 vaccine headlines boosted optimism among traders.
US economic activity hits March 2015 highs, IHS Markit says
The fourth wave of Covid-19 infections in the US failed to dent the economic rebound in the US, the results of two closely-followed surveys revealed.
FTSE 100 movers: IAG rallies; AstraZeneca loses ground
London’s FTSE 100 was down 0. 1% at 6,342. 37 in afternoon trade on Monday.
Avacta reports 'significant progress' on Covid-19 test
Cancer therapies and diagnostics developer Avacta Group announced “significant progress” in the development of a scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test being carried out with BBI Solutions on Monday.
FCA fines broker TFS-ICAP £3.4m
The Financial Conduct Authority has fined TFS-ICAP more than £3m after it ruled the forex options broker had mislead customers.
Codemasters H1 revenues more than double on game releases
Video game developer Codemasters said on Monday that first-half revenues more than doubled and operating profit rose as it released three new games.
Proof of Covid-19 vaccination may be required for travel, says Qantas
International passengers will only be able to travel on Qantas flights if they have been vaccinated against Covid-19, the airline’s chief executive has suggested.
Galileo reports 'very promising' results from Kalahari Copper Belt
Galileo Resources updated the market on exploration at its wholly-held property in the emerging Kalahari Copper Belt in western Botswana on Monday.
Cake Box interim profits, revenue dip after lockdown
Specialist cake retailer Cake Box reported a dip in interim profit and revenue on Monday after its stores were forced to close due to Covid-19 restrictions.
RBC upgrades SSE to 'outperform' on green targets
Royal Bank of Canada upgraded SSE to 'outperform' as the bank took a more positive view of the group's green energy targets and the regulatory outlook.